J Hamann

Summary

Affiliation: Klinikum rechts der Isar
Country: Germany

Publications

  1. ncbi request reprint Do patients with schizophrenia wish to be involved in decisions about their medical treatment?
    Johannes Hamann
    Klinik und Poliklinik fur Psychiatrie und Psychotherapie, Möhlstrasse 26, 81675 Munchen, Germany
    Am J Psychiatry 162:2382-4. 2005
  2. ncbi request reprint Effects of an integrated care program for outpatients with affective or psychotic disorders
    Johannes Hamann
    Klinik und Poliklinik fur Psychiatrie und Psychotherapie der Technischen Universitat Munchen, Munchen, Germany Electronic address
    Psychiatry Res 217:15-9. 2014
  3. doi request reprint [Understanding the term burnout in psychiatry and psychotherapy]
    J Hamann
    Klinik und Poliklinik fur Psychiatrie und Psychotherapie, Technische Universitat Munchen, Möhlstr 26, 81675 Munchen, Deutschland
    Nervenarzt 84:838-43. 2013
  4. doi request reprint Psychiatrists' decision making between branded and generic drugs
    Johannes Hamann
    Psychiatric Department, Technical University Munich, Munich, Germany
    Eur Neuropsychopharmacol 23:686-90. 2013
  5. doi request reprint How should patients behave to facilitate shared decision making--the doctors' view
    Johannes Hamann
    Klinik und Poliklinik fur Psychiatrie und Psychotherapie, Technische Universitat Munchen, Munich, Germany
    Health Expect 15:360-6. 2012
  6. doi request reprint How do patients from eastern and western Germany compare with regard to their preferences for shared decision making?
    Johannes Hamann
    Klinik und Poliklinik fur Psychiatrie und Psychotherapie, Technische Universitat Munchen, Germany
    Eur J Public Health 22:469-73. 2012
  7. ncbi request reprint Patient participation in antipsychotic drug choice decisions
    Johannes Hamann
    Department of Psychiatry and Psychotherapy, Technische Universitat Munchen, Germany
    Psychiatry Res 178:63-7. 2010
  8. ncbi request reprint Participation preferences of patients with acute and chronic conditions
    Johannes Hamann
    Klinik und Poliklinik für Psychiatrie und Psychotherapie der TU München, Munchen, Germany
    Health Expect 10:358-63. 2007
  9. ncbi request reprint Shared decision making and long-term outcome in schizophrenia treatment
    Johannes Hamann
    Department of Psychiatry, Technische Universitat, Munich, Germany
    J Clin Psychiatry 68:992-7. 2007
  10. ncbi request reprint Shared decision making for in-patients with schizophrenia
    J Hamann
    Psychiatric Department, Klinik und Poliklinik fur Psychiatrie und Psychotherapie, Technische Universitat Munchen, Möhlstrasse 26, 81675 Munich, Germany
    Acta Psychiatr Scand 114:265-73. 2006

Detail Information

Publications48

  1. ncbi request reprint Do patients with schizophrenia wish to be involved in decisions about their medical treatment?
    Johannes Hamann
    Klinik und Poliklinik fur Psychiatrie und Psychotherapie, Möhlstrasse 26, 81675 Munchen, Germany
    Am J Psychiatry 162:2382-4. 2005
    ..Little is known about the desire of patients with schizophrenia to be involved in medical decisions affecting their treatment...
  2. ncbi request reprint Effects of an integrated care program for outpatients with affective or psychotic disorders
    Johannes Hamann
    Klinik und Poliklinik fur Psychiatrie und Psychotherapie der Technischen Universitat Munchen, Munchen, Germany Electronic address
    Psychiatry Res 217:15-9. 2014
    ....
  3. doi request reprint [Understanding the term burnout in psychiatry and psychotherapy]
    J Hamann
    Klinik und Poliklinik fur Psychiatrie und Psychotherapie, Technische Universitat Munchen, Möhlstr 26, 81675 Munchen, Deutschland
    Nervenarzt 84:838-43. 2013
    ..Currently there is much debate about the concept of burnout and its use as a diagnostic entity. The aim of the present survey was to present the view of mental health professionals towards the concept of burnout...
  4. doi request reprint Psychiatrists' decision making between branded and generic drugs
    Johannes Hamann
    Psychiatric Department, Technical University Munich, Munich, Germany
    Eur Neuropsychopharmacol 23:686-90. 2013
    ....
  5. doi request reprint How should patients behave to facilitate shared decision making--the doctors' view
    Johannes Hamann
    Klinik und Poliklinik fur Psychiatrie und Psychotherapie, Technische Universitat Munchen, Munich, Germany
    Health Expect 15:360-6. 2012
    ..Participants were requested to judge which patient behaviours they find helpful and which behaviours detrimental for SDM...
  6. doi request reprint How do patients from eastern and western Germany compare with regard to their preferences for shared decision making?
    Johannes Hamann
    Klinik und Poliklinik fur Psychiatrie und Psychotherapie, Technische Universitat Munchen, Germany
    Eur J Public Health 22:469-73. 2012
    ..This shift towards more patient engagement by health professionals and towards more desire by patients for participation may be partly based on socio-political factors...
  7. ncbi request reprint Patient participation in antipsychotic drug choice decisions
    Johannes Hamann
    Department of Psychiatry and Psychotherapy, Technische Universitat Munchen, Germany
    Psychiatry Res 178:63-7. 2010
    ..When working with patients exhibiting poor insight and negative drug attitudes, psychiatrists use authoritative decision-making styles despite the patient's desire to participate...
  8. ncbi request reprint Participation preferences of patients with acute and chronic conditions
    Johannes Hamann
    Klinik und Poliklinik für Psychiatrie und Psychotherapie der TU München, Munchen, Germany
    Health Expect 10:358-63. 2007
    ..There is little knowledge as to whether the chronicity of a disease affects patients' desire for participation...
  9. ncbi request reprint Shared decision making and long-term outcome in schizophrenia treatment
    Johannes Hamann
    Department of Psychiatry, Technische Universitat, Munich, Germany
    J Clin Psychiatry 68:992-7. 2007
    ..The aim of the present analysis was to study whether shared decision making (SDM) in antipsychotic drug choice would influence long-term outcome...
  10. ncbi request reprint Shared decision making for in-patients with schizophrenia
    J Hamann
    Psychiatric Department, Klinik und Poliklinik fur Psychiatrie und Psychotherapie, Technische Universitat Munchen, Möhlstrasse 26, 81675 Munich, Germany
    Acta Psychiatr Scand 114:265-73. 2006
    ..In the present study, the feasibility and effects of SDM for in-patients with schizophrenia should be evaluated...
  11. ncbi request reprint Psychiatric decision making in the adoption of a new antipsychotic in Germany
    Johannes Hamann
    Technische Universitat Munchen, Möhlstrasse 26, Muenchen, Germany 81675
    Psychiatr Serv 57:700-3. 2006
    ..Studies in somatic medicine have demonstrated delays in the implementation of new drugs, but data on psychiatric drugs are scarce. This study examined psychiatrists' adoption of a new antipsychotic...
  12. doi request reprint [Complaint-management in psychiatry - a nationwide survey in Germany]
    Johannes Hamann
    Klinik und Poliklinik fur Psychiatrie und Psychotherapie der Technischen Universitat Munchen
    Psychiatr Prax 35:122-7. 2008
    ..To describe and characterize the work of independent complaint offices for users of psychiatric services and of ombudsmen in psychiatric hospitals...
  13. doi request reprint Patients' and psychiatrists' perceptions of clinical decisions during schizophrenia treatment
    Johannes Hamann
    Klinik und Poliklinik für Psychiatrie und Psychotherapie der TU München, Munchen, Germany
    J Nerv Ment Dis 196:329-32. 2008
    ..This is especially true of those being treated involuntarily...
  14. doi request reprint Psychiatrists' use of shared decision making in the treatment of schizophrenia: patient characteristics and decision topics
    Johannes Hamann
    Department of Psychiatry, Technische Universitat Munchen, Möhlstrasse 26, 81675 Munchen, Germany
    Psychiatr Serv 60:1107-12. 2009
    ..This study explored psychiatrists' views of shared decision making in schizophrenia treatment...
  15. doi request reprint How much more effective do depot antipsychotics have to be compared to oral antipsychotics before they are prescribed?
    Johannes Hamann
    Klinik und Poliklinik fur Psychiatrie und Psychotherapie, Technische Universitat Munchen, Germany
    Eur Neuropsychopharmacol 20:276-9. 2010
    ..Other psychiatrist-related factors (e.g. age, gender, and work experience) did not influence attitudes toward depot...
  16. doi request reprint Can psychiatrists and neurologists predict their patients' participation preferences?
    Johannes Hamann
    Klinik und Poliklinik fur Psychiatrie und Psychotherapie, Technische Universitat Munchen, Munchen, Germany
    J Nerv Ment Dis 198:309-11. 2010
    ..More attention in the consultation should be paid to patients' preferences...
  17. doi request reprint Why do some patients with schizophrenia want to be engaged in medical decision making and others do not?
    Johannes Hamann
    Departments of Psychiatry and Psychotherapy, Technical University Munich, Munich, Germany
    J Clin Psychiatry 72:1636-43. 2011
    ..Our goal was to determine why some patients want to participate in medical decision making and others do not...
  18. doi request reprint "How to speak to your psychiatrist": shared decision-making training for inpatients with schizophrenia
    Johannes Hamann
    Psychiatric Department, Technische Universitat Munchen, Munich, Germany
    Psychiatr Serv 62:1218-21. 2011
    ..This study evaluated a new intervention...
  19. ncbi request reprint Physicians' and patients' involvement in relapse prevention with antipsychotics in schizophrenia
    Johannes Hamann
    Psychiatry Department, Technische Universitat Munchen, Germany
    Psychiatr Serv 56:1448-50. 2005
    ..Accordingly, patients' knowledge of the optimal duration of maintenance therapy was poor...
  20. ncbi request reprint Shared decision making in psychiatry
    J Hamann
    Department of Psychiatry and Psychotherapy, Center for Disease Management, Technical University Munich, Germany
    Acta Psychiatr Scand 107:403-9. 2003
    ..In other medical fields, 'shared decision making' (a strategy for including patients in therapeutic decision processes) has been studied for several years now. This survey presents the potential of shared decision making for psychiatry...
  21. ncbi request reprint Antipsychotic prescribing patterns in Germany: a retrospective analysis using a large outpatient prescription database
    Johannes Hamann
    Center for Disease Management, Klinik und Poliklinik fur Psychiatrie und Psychotherapie der Technischen Universitat Munchen, Munchen, Germany
    Int Clin Psychopharmacol 18:237-42. 2003
    ..It is important to raise awareness among non-specialists about the indications, efficacy and side-effects of the antipsychotics because these physicians account for the majority of antipsychotic prescriptions...
  22. ncbi request reprint Are patients with schizophrenia under-treated with second-generation antipsychotics? A pilot study of the prescription practices of German psychiatrists
    J Hamann
    Klinik und Poliklinik fur Psychiatrie und Psychotherapie der Technischen Universitat Munchen, Munchen, Germany
    Pharmacopsychiatry 36:309-12. 2003
    ..They estimate that only about 10- 30 % of all patients with schizophrenia receive second-generation antipsychotics, a figure that lies significantly below the international average...
  23. ncbi request reprint [Shared decision making--from a model project towards implementation]
    Johannes Hamann
    Klinik und Poliklinik fur Psychiatrie und Psychotherapie der Technischen Universitat Munchen
    Z Arztl Fortbild Qualitatssich 98:115-9. 2004
    ..Rather, there is an urgent need to encourage and empower patients to claim their rights to information and participation...
  24. ncbi request reprint Are the second-generation antipsychotics cost-effective? A critical review on the background of different health systems
    J Hamann
    Klinik für Psychiatrie und Psychotherapie der Technischen Universität München
    Pharmacopsychiatry 36:18-26. 2003
    ..This has been criticized on the grounds that the higher acquisition costs of the new antipsychotics might be more than outweighed by savings in other fields, e. g., through a reduction in rehospitalizations or indirect costs...
  25. ncbi request reprint Postoperative acute confusional state in typical urologic population: incidence, risk factors, and strategies for prevention
    Johannes Hamann
    Department of Psychiatry and Psychotherapy, Klinikum rechts der Isar, Technical University Munich, Munich, Germany
    Urology 65:449-53. 2005
    ..Only a few studies, of highly selected urologic procedures, have been reported, and all showed an astonishingly low percentage of patients with this distressing condition...
  26. ncbi request reprint [Effects of a shared decision making model in psychiatric and neurologic practice]
    J Hamann
    Klinik und Poliklinik fur Psychiatrie und Psychotherapie der Technischen Universitat Munchen, Germany
    Nervenarzt 77:1071-6, 1078. 2006
    ..This report provides a survey of this shared decision making model and a discussion of its implications in the fields of mental health and neurology...
  27. ncbi request reprint How do psychiatrists choose among different antipsychotics?
    Johannes Hamann
    Department for Psychiatry and Psychotherapy, Technische Universitat, Möhlstrasse 26, 81675 Munich, Germany
    Eur J Clin Pharmacol 61:851-4. 2005
    ..We attempted to determine the decision rules psychiatrists use in the choice of antipsychotic drugs for inpatients with schizophrenia...
  28. doi request reprint Patient participation in medical and social decisions in Alzheimer's disease
    Johannes Hamann
    Department of Psychiatry, Technische Universitat Munchen, Munchen, Germany
    J Am Geriatr Soc 59:2045-52. 2011
    ....
  29. doi request reprint Confirmation bias: why psychiatrists stick to wrong preliminary diagnoses
    R Mendel
    Department of Psychiatry, Technische Universitat Munchen, Germany
    Psychol Med 41:2651-9. 2011
    ..Experts assume that physicians' desire to confirm a preliminary diagnosis while failing to seek contradictory evidence is an important reason for wrong diagnoses. This tendency is called 'confirmation bias'...
  30. doi request reprint How psychiatrists inform themselves and their patients about risks and benefits of antipsychotic treatment
    R Mendel
    Department of Psychiatry, Technische Universitat Munchen, Munich, Germany
    Acta Psychiatr Scand 120:112-9. 2009
    ..Our study aims to investigate whether psychiatrists actually do conduct such a balanced information search and presentation...
  31. ncbi request reprint Clinical implications of Brief Psychiatric Rating Scale scores
    Stefan Leucht
    Klinik fürr Psychiatrie und Psychotherapie derTechnischen Universität München, Klinikum rechts der Isar, Ismaningerstrasse 22, 81675 Munchen, Germany
    Br J Psychiatry 187:366-71. 2005
    ..Despite the widespread use of the Brief Psychiatric Rating Scale (BPRS), the clinical meaning of its total score and cut-off values used to define treatment response are unclear...
  32. ncbi request reprint Medical decision making in antipsychotic drug choice for schizophrenia
    Johannes Hamann
    Psychiatric Department, Technical University of Munich, Möhlstrasse 26, 81675 Munich, Germany
    Am J Psychiatry 161:1301-4. 2004
    ..The influence of patient and physician variables on antipsychotic drug choice for patients with schizophrenia was assessed...
  33. doi request reprint Psychiatrists' attitude to antipsychotic depot treatment in patients with first-episode schizophrenia
    S Heres
    Klinik und Poliklinik fuer Psychiatrie und Psychotherapie, der Technischen Universitaet Muenchen, am Klinikum rechts der Isar, Moehlstrasse 26, 81675 Muenchen, Germany
    Eur Psychiatry 26:297-301. 2011
    ..Despite good clinical evidence, depot antipsychotics are only seldom prescribed to patients with first episode schizophrenia. The present study aims at investigating psychiatrists' reasons for this reservation...
  34. ncbi request reprint Early-onset hypothesis of antipsychotic drug action: a hypothesis tested, confirmed and extended
    Stefan Leucht
    Department of Psychiatry and Psychotherapy, Klinikum rechts der Isar der Technischen Universitat Munchen, Munich, Germany
    Biol Psychiatry 57:1543-9. 2005
    ....
  35. ncbi request reprint Linking the PANSS, BPRS, and CGI: clinical implications
    Stefan Leucht
    Klinik für Psychiatrie und Psychotherapie der TU München, Klinikum rechts der Isar, Munich, Munchen, Germany
    Neuropsychopharmacology 31:2318-25. 2006
    ..Clinicians seem to base CGI ratings on relative change rather than on absolute change of symptoms...
  36. ncbi request reprint Amisulpride is an "atypical" antipsychotic associated with low weight gain
    Stefan Leucht
    Department of Psychiatry and Psychotherapy, Klinikum rechts der Isar der Technischen Universitat Munchen, Ismaningerstrasse 22, 81675 Munich, Germany
    Psychopharmacology (Berl) 173:112-5. 2004
    ..While most "atypicals" have a high affinity for both dopamine and serotonin receptors, amisulpride has only dopamine receptor action...
  37. ncbi request reprint New generation antipsychotics versus low-potency conventional antipsychotics: a systematic review and meta-analysis
    Stefan Leucht
    Klinik und Poliklinik fur Psychiatrie und Psychotherapie der Technischen Universitat Munchen, Klinikum rechts der Isar, Munchen, Germany
    Lancet 361:1581-9. 2003
    ..We aimed to establish whether the new drugs induce fewer EPS than low-potency conventional antipsychotics...
  38. doi request reprint 'What would you do if you were me, doctor?': randomised trial of psychiatrists' personal v. professional perspectives on treatment recommendations
    Rosmarie Mendel
    Department of Psychiatry, Technische Universitat Munchen, Munchen, Germany
    Br J Psychiatry 197:441-7. 2010
    ....
  39. ncbi request reprint Attitudes of psychiatrists toward antipsychotic depot medication
    Stephan Heres
    Klinik und Poliklinik fuer Psychiatrie und Psychotherapie der Technischen, Universitaet Muenchen am Klinikum rechts der, Muenchen, Germany
    J Clin Psychiatry 67:1948-53. 2006
    ..Nevertheless, long-acting injectable formulations are seldom prescribed in the treatment of schizophrenia...
  40. doi request reprint [Patient participation in german psychiatry - a critical review]
    Tatjana Reichhart
    Centrum für Disease Management, Klinik und Poliklinik fur Psychiatrie und Psychotherapie der Technischen Universitat Munchen
    Psychiatr Prax 35:111-21. 2008
    ..A comprehensive review of the present state and new approaches of patient participation in German psychiatry was conducted...
  41. ncbi request reprint What does the PANSS mean?
    Stefan Leucht
    Klinik für Psychiatrie und Psychotherapie der TU München Klinikum rechts der Isar, Ismaningerstr 22, 81675 Munchen, Germany
    Schizophr Res 79:231-8. 2005
    ..g. at least 20% or 50% reduction of the baseline score) are as yet unclear. We therefore compared the PANSS with simultaneous ratings of Clinical Global Impressions (CGI)...
  42. doi request reprint Identifying the profile of optimal candidates for antipsychotic depot therapy A cluster analysis
    Stephan Heres
    Klinik und Poliklinik fuer Psychiatrie und Psychotherapie der Technischen Universitaet Muenchen am Klinikum rechts der Isar, Moehlstrasse 26, 81675 Muenchen, Germany
    Prog Neuropsychopharmacol Biol Psychiatry 32:1987-93. 2008
    ..In a first step to highlight this contradiction we aimed at identifying attributes of patients that indicate their qualification for depot treatment in the eyes of the psychiatrists...
  43. pmc Methodological issues in current antipsychotic drug trials
    Stefan Leucht
    Department of Psychiatry and Psychotherapy, Klinikum rechts der Isar der Technischen Universitat Munchen, Ismaningerstr 22, 81675 Munchen, Germany
    Schizophr Bull 34:275-85. 2008
    ..The authors present practical examples to highlight the current problems and propose a concrete series of suggestions on how to further optimize antipsychotic drug trials in the future...
  44. ncbi request reprint Language bias in neuroscience--is the Tower of Babel located in Germany?
    S Heres
    Psychiatrische Klinik und Poliklinik, Technischen Universitaet Muenchen, Klinikum rechts der Isar, Ismaningerstrasse 22, Munich 81675, Germany
    Eur Psychiatry 19:230-2. 2004
    ..In the neurosciences a similar trend was seen but the findings were not statistically significant. The reason for this inconclusive finding might be the low number of RCTs published in German...
  45. ncbi request reprint Over-the-Counter-Drugs for the Treatment of Mood and Anxiety Disorders - The Views of German Pharmacists
    J Hamann
    Psychiatrie und Psychotherapie, TU Munchen, Munchen, Germany
    Pharmacopsychiatry 47:84-8. 2014
    ..It is unclear whether this constitutes a rational and cost effective method to deal with mild courses of high prevalence diseases or must be seen critically. ..
  46. ncbi request reprint Medical decision making in the mental health field
    Johannes Hamann
    Psychiatr Serv 56:221. 2005
  47. ncbi request reprint Pretrial medication bias in randomized antipsychotic drug trials
    Stefan Leucht
    Am J Psychiatry 164:1266; author reply 1266-7. 2007
  48. ncbi request reprint Medication adherence studies in schizophrenia
    Johannes Hamann
    Am J Psychiatry 161:582; author reply 582-3. 2004